Theranos inks insurance deal; Illumina farms animal health market with genetic tests;

> Theranos struck a deal with a Pennsylvania insurer to become its preferred lab-work provider. Story

> Illumina ($ILMN) inked an agreement with animal health outfit Neogen ($NEOG) to market its genetic tests to labs. More

> PDI's ($PDII) Interpace Diagnostics unit snagged a positive coverage decision from Aetna ($AET) for its thyroid mutation panel. Statement

> Lexington, MA-based Quanterix is mulling an IPO to ramp up development for its blood biomarker diagnostic device. Story

> Accelerate Diagnostics nabbed a CE mark for its rapid infectious disease testing system. More

> OraSure Technologies ($OSUR) subsidiary DNA Genotek got an EU blessing for its microbiome collection kit. Statement

And Finally… A Philadelphia startup is developing a card-sized, flushable pregnancy test. Story

Suggested Articles

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.

In one of the longest studies to date in high-risk heart disease, researchers found no significant difference in death rates over more than 10 years.